These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9111993)

  • 1. A Cys634Gly substitution of the RET proto-oncogene in a family with recurrence of multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis.
    Seri M; Celli I; Betsos N; Claudiani F; Camera G; Romeo G
    Clin Genet; 1997 Feb; 51(2):86-90. PubMed ID: 9111993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Type 2A multiple endocrine neoplasia with cutaneous lichen amyloidosis].
    Brändle M; Schlaeppi M; Schmid C
    Schweiz Med Wochenschr; 2000 Jun; 130(22):861. PubMed ID: 10893758
    [No Abstract]   [Full Text] [Related]  

  • 3. Early onset of medullary thyroid carcinoma in a kindred with multiple endocrine neoplasia type iia associated with cutaneous lichen amyloidosis.
    Lemos MC; Carrilho F; Rodrigues FJ; Santos P; Carvalheiro M; Ruas MA; Regateiro FJ
    Endocr Pract; 2002; 8(1):19-22. PubMed ID: 11939755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
    Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
    Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.
    Moers AM; Landsvater RM; Schaap C; Jansen-Schillhorn van Veen JM; de Valk IA; Blijham GH; Höppener JW; Vroom TM; van Amstel HK; Lips CJ
    Am J Med; 1996 Dec; 101(6):635-41. PubMed ID: 9003111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RET mutation screening in familial cutaneous lichen amyloidosis and in skin amyloidosis associated with multiple endocrine neoplasia.
    Hofstra RM; Sijmons RH; Stelwagen T; Stulp RP; Kousseff BG; Lips CJ; Steijlen PM; Van Voorst Vader PC; Buys CH
    J Invest Dermatol; 1996 Aug; 107(2):215-8. PubMed ID: 8757765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of MEN 2a in familial Hirschsprung's disease: a new indication for genetic testing of the RET proto-oncogene.
    Decker RA; Peacock ML
    J Pediatr Surg; 1998 Feb; 33(2):207-14. PubMed ID: 9498388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of RET codon 768 is associated with the FMTC phenotype.
    Boccia LM; Green JS; Joyce C; Eng C; Taylor SA; Mulligan LM
    Clin Genet; 1997 Feb; 51(2):81-5. PubMed ID: 9111992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
    Kambouris M; Jackson CE; Feldman GL
    Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families.
    Marsh DJ; McDowall D; Hyland VJ; Andrew SD; Schnitzler M; Gaskin EL; Nevell DF; Diamond T; Delbridge L; Clifton-Bligh P; Robinson BG
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):213-20. PubMed ID: 8849577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of ret proto-oncogene in 3 Korean families with MEN 2A: clinical use of new restriction sites for genetic diagnosis.
    Lee MS; Hwang DY; Kim YH; Chung JH; Oh YS; Lee MK; Kim KW
    Endocr J; 1998 Aug; 45(4):555-61. PubMed ID: 9881906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent association between MEN 2A and cutaneous lichen amyloidosis.
    Verga U; Fugazzola L; Cambiaghi S; Pritelli C; Alessi E; Cortelazzi D; Gangi E; Beck-Peccoz P
    Clin Endocrinol (Oxf); 2003 Aug; 59(2):156-61. PubMed ID: 12864791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease.
    Pasini B; Rossi R; Ambrosio MR; Zatelli MC; Gullo M; Gobbo M; Collini P; Aiello A; Pansini G; Trasforini G; degli Uberti EC
    Surgery; 2002 Apr; 131(4):373-81. PubMed ID: 11935126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of the C634Y mutation in the RET proto-oncogene in MEN 2A families in Spain.
    Sánchez B; Robledo M; Biarnes J; Sáez ME; Volpini V; Benítez J; Navarro E; Ruiz A; Antiñolo G; Borrego S
    J Med Genet; 1999 Jan; 36(1):68-70. PubMed ID: 9950371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A.
    Landsvater RM; Jansen RP; Hofstra RM; Buys CH; Lips CJ; Ploos van Amstel HK
    Hum Genet; 1996 Jan; 97(1):11-4. PubMed ID: 8557249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A.
    Berndt I; Reuter M; Saller B; Frank-Raue K; Groth P; Grussendorf M; Raue F; Ritter MM; Höppner W
    J Clin Endocrinol Metab; 1998 Mar; 83(3):770-4. PubMed ID: 9506724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma.
    Karga HJ; Karayianni MK; Linos DA; Tseleni SC; Karaiskos KD; Papapetrou PD
    Eur J Endocrinol; 1998 Oct; 139(4):410-5. PubMed ID: 9820617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.